{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:15:37Z","timestamp":1783160137354,"version":"3.54.6"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["ZD2021CY001"],"award-info":[{"award-number":["ZD2021CY001"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.virusres.2026.199735","type":"journal-article","created":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:57:56Z","timestamp":1777183076000},"page":"199735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and protective evaluation of mRNA vaccines encoding the glycoprotein precursor of lymphocytic choriomeningitis virus"],"prefix":"10.1016","volume":"368","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-7831-0569","authenticated-orcid":false,"given":"Yongli","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7329-5688","authenticated-orcid":false,"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2416-7708","authenticated-orcid":false,"given":"Youhua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2026.199735_bib0001","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.immuni.2021.11.001","article-title":"Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses","volume":"54","author":"Alameh","year":"2021","journal-title":"Immunity."},{"key":"10.1016\/j.virusres.2026.199735_bib0002","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2026.199735_bib0003","doi-asserted-by":"crossref","first-page":"21641","DOI":"10.1073\/pnas.1011998107","article-title":"Viral replicative capacity is the primary determinant of lymphocytic choriomeningitis virus persistence and immunosuppression","volume":"107","author":"Bergthaler","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virusres.2026.199735_bib0004","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4049\/jimmunol.2200320","article-title":"Novel lymphocytic choriomeningitis virus strain sustains abundant exhausted progenitor CD8 T cells without systemic viremia","volume":"209","author":"Beura","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.virusres.2026.199735_bib0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.coviro.2016.04.001","article-title":"Native functionality and therapeutic targeting of arenaviral glycoproteins","volume":"18","author":"Crispin","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0006","first-page":"16","article-title":"Inactivation validation of Ebola, Marburg, and Lassa viruses in AVL and ethanol-treated viral cultures","author":"Cutts","year":"2024","journal-title":"Viruses."},{"key":"10.1016\/j.virusres.2026.199735_bib0007","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1084\/jem.20061462","article-title":"Resolution of a chronic viral infection after interleukin-10 receptor blockade","volume":"203","author":"Ejrnaes","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virusres.2026.199735_bib0008","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1128\/JVI.02102-10","article-title":"Rescue from cloned cDNAs and in vivo characterization of recombinant pathogenic Romero and live-attenuated candid #1 strains of Junin virus, the causative agent of Argentine hemorrhagic fever disease","volume":"85","author":"Emonet","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0009","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1056\/NEJMoa053240","article-title":"Transmission of lymphocytic choriomeningitis virus by organ transplantation","volume":"354","author":"Fischer","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virusres.2026.199735_bib0010","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1371\/journal.pmed.0020183","article-title":"Development of a new vaccine for the prevention of Lassa fever","volume":"2","author":"Geisbert","year":"2005","journal-title":"PLoS. Med."},{"key":"10.1016\/j.virusres.2026.199735_bib0011","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00578-24","article-title":"An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice","volume":"98","author":"Hashizume","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0012","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nsmb.3210","article-title":"Crystal structure of the prefusion surface glycoprotein of the prototypic arenavirus LCMV","volume":"23","author":"Hastie","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virusres.2026.199735_bib0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coviro.2021.03.008","article-title":"Future considerations for the mRNA-lipid nanoparticle vaccine platform","volume":"48","author":"IGY\u00c1RT\u00d3","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0014","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.ajog.2005.11.040","article-title":"Lymphocytic choriomeningitis virus: an emerging obstetric pathogen?","volume":"194","author":"Jamieson","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.virusres.2026.199735_bib0015","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1128\/JVI.02632-06","article-title":"The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus","volume":"81","author":"Kotturi","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0016","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.immuni.2020.07.019","article-title":"A single immunization with nucleoside-modified mRNA vaccines elicits strong cellular and humoral immune responses against SARS-CoV-2 in mice","volume":"53","author":"Laczk\u00f3","year":"2020","journal-title":"Immunity."},{"key":"10.1016\/j.virusres.2026.199735_bib0017","article-title":"mRNA vaccines: current applications and future directions","volume":"6","author":"Li","year":"2025","journal-title":"Med. Comm. (2020)"},{"key":"10.1016\/j.virusres.2026.199735_bib0018","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/eji.200838282","article-title":"In vivo conversion of BM plasmacytoid DC into CD11b+ conventional DC during virus infection","volume":"38","author":"Liou","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virusres.2026.199735_bib0019","doi-asserted-by":"crossref","first-page":"13934","DOI":"10.1128\/JVI.79.22.13934-13942.2005","article-title":"A live attenuated vaccine for Lassa fever made by reassortment of Lassa and Mopeia viruses","volume":"79","author":"Lukashevich","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0020","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1038\/s41564-025-02085-6","article-title":"Molecular organization of the New World arenavirus spike glycoprotein complex","volume":"10","author":"Mann","year":"2025","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.virusres.2026.199735_bib0021","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/14760584.2016.1182024","article-title":"Novel strategies for development of hemorrhagic fever arenavirus live-attenuated vaccines","volume":"15","author":"Martinez-Sobrido","year":"2016","journal-title":"Expert. Rev. Vaccines."},{"key":"10.1016\/j.virusres.2026.199735_bib0022","first-page":"11","article-title":"Vaccines inducing immunity to Lassa virus glycoprotein and nucleoprotein protect macaques after a single shot","author":"Mateo","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.virusres.2026.199735_bib0023","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1128\/jvi.68.12.8056-8063.1994","article-title":"CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection","volume":"68","author":"Matloubian","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0024","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jviromet.2007.08.025","article-title":"Quantitative PCR technique for detecting lymphocytic choriomeningitis virus in vivo","volume":"147","author":"Mccausland","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.virusres.2026.199735_bib0025","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/mt.2011.67","article-title":"Therapeutic delivery of mRNA: the medium is the message","volume":"19","author":"Mcivor","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2026.199735_bib0026","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.chembiol.2023.03.005","article-title":"Structural basis for antibody-mediated neutralization of lymphocytic choriomeningitis virus","volume":"30","author":"Moon-Walker","year":"2023","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.virusres.2026.199735_bib0027","doi-asserted-by":"crossref","first-page":"E7814","DOI":"10.1073\/pnas.1804674115","article-title":"Lymphocytic choriomeningitis virus Clone 13 infection causes either persistence or acute death dependent on IFN-1, cytotoxic T lymphocytes (CTLs), and host genetics","volume":"115","author":"Oldstone","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virusres.2026.199735_bib0028","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.virusres.2026.199735_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/952387a7-96a0-44f6-98a6-2d7c7b472b0a","article-title":"Old world arenaviruses enter the host cell via the multivesicular body and depend on the endosomal sorting complex required for transport","volume":"7","author":"Pasqual","year":"2011","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.virusres.2026.199735_bib0030","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-3-319-75474-1_3","article-title":"Cleavage of the glycoprotein of arenaviruses","author":"Pasquato","year":"2018","journal-title":"Activation of Viruses by Host Proteases"},{"key":"10.1016\/j.virusres.2026.199735_bib0031","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI200422374","article-title":"Kinetics of protective antibodies are determined by the viral surface antigen","volume":"114","author":"Pinschewer","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.virusres.2026.199735_bib0032","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s10875-019-00642-3","article-title":"Life-threatening infections due to live-attenuated vaccines: early manifestations of inborn errors of immunity","volume":"39","author":"P\u00d6YH\u00d6NEN","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.virusres.2026.199735_bib0033","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1128\/JVI.02229-10","article-title":"Use of single-cycle infectious lymphocytic choriomeningitis virus to study hemorrhagic fever arenaviruses","volume":"85","author":"Rodrigo","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0034","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1128\/JVI.01331-07","article-title":"Cellular entry of lymphocytic choriomeningitis virus","volume":"82","author":"Rojek","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0035","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1038\/s41467-023-41376-6","article-title":"A Lassa virus mRNA vaccine confers protection but does not require neutralizing antibody in a guinea pig model of infection","volume":"14","author":"Ronk","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virusres.2026.199735_bib0036","first-page":"11","article-title":"Vaccine candidates against arenavirus infections","author":"Saito","year":"2023","journal-title":"Vaccines. (Basel)"},{"key":"10.1016\/j.virusres.2026.199735_bib0037","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1084\/jem.192.9.1249","article-title":"Immunosuppression and resultant viral persistence by specific viral targeting of dendritic cells","volume":"192","author":"Sevilla","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virusres.2026.199735_bib0038","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1128\/JVI.75.1.448-457.2001","article-title":"Differences in affinity of binding of lymphocytic choriomeningitis virus strains to the cellular receptor alpha-dystroglycan correlate with viral tropism and disease kinetics","volume":"75","author":"Smelt","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005276","article-title":"Arenavirus glycan shield promotes neutralizing antibody evasion and protracted infection","volume":"11","author":"Sommerstein","year":"2015","journal-title":"PLoS. Pathog."},{"key":"10.1016\/j.virusres.2026.199735_bib0040","doi-asserted-by":"crossref","first-page":"8556","DOI":"10.1128\/JVI.01133-14","article-title":"Inhibition of arenavirus infection by a glycoprotein-derived peptide with a novel mechanism","volume":"88","author":"Spence","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0041","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1073\/pnas.1019304108","article-title":"Point mutation in the glycoprotein of lymphocytic choriomeningitis virus is necessary for receptor binding, dendritic cell infection, and long-term persistence","volume":"108","author":"Sullivan","year":"2011","journal-title":"Proc. Natl. Acad. Sci. u S. a"},{"key":"10.1016\/j.virusres.2026.199735_bib0042","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.3390\/v4091802","article-title":"Animal models, prophylaxis, and therapeutics for arenavirus infections","volume":"4","author":"Vela","year":"2012","journal-title":"Viruses."},{"key":"10.1016\/j.virusres.2026.199735_bib0043","doi-asserted-by":"crossref","first-page":"4911","DOI":"10.1128\/JVI.77.8.4911-4927.2003","article-title":"Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment","volume":"77","author":"Wherry","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2026.199735_bib0044","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity."},{"key":"10.1016\/j.virusres.2026.199735_bib0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s12276-023-00991-5","article-title":"Chronic LCMV infection regulates the effector T cell response by inducing the generation of less immunogenic dendritic cells","volume":"55","author":"Yoo","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.virusres.2026.199735_bib0046","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1084\/jem.188.12.2205","article-title":"Viral immune evasion due to persistence of activated T cells without effector function","volume":"188","author":"Zajac","year":"1998","journal-title":"J. Exp. Med."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226000547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:17:31Z","timestamp":1783156651000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":46,"alternative-id":["S0168170226000547"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199735","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and protective evaluation of mRNA vaccines encoding the glycoprotein precursor of lymphocytic choriomeningitis virus","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199735"}}